How should Trenbolone Hexahydrobenzylcarbonate dosing be structured during the competition prep phase?

Competition-phase dosing is typically lower and more precisely controlled than off-season use, with weekly targets commonly ranging from 150mg to 230mg split across two injections. At 76.5mg/ml, each injection volume falls between 0.98ml and 1.50ml, allowing fine volumetric adjustments as the contest date approaches. The goal is androgenic tissue support under a caloric deficit, not maximum anabolic stimulus.

How many weeks before a competition should Parabolan 76.5mg/ml be introduced into a prep cycle?

Most competition-focused protocols introduce Trenbolone Hexahydrobenzylcarbonate eight to twelve weeks out from the contest date. This window allows plasma concentrations to stabilise before the critical final four weeks, where the compound's role in lean tissue preservation and hardening becomes most important. Earlier introduction provides more time to assess individual tolerance and adjust the weekly dose.

Is dose reduction recommended in peak week before a competition, and how is it calculated with 76.5mg/ml?

Many athletes and coaching teams deliberately reduce androgenic load in peak week to manage water retention and cardiovascular stress. With Swiss Pharma's 76.5mg/ml concentration, reducing each injection by 0.2ml lowers the per-injection dose by precisely 15.3mg — a meaningful step-down that offers finer control than 100mg/ml formulations, where the same 0.2ml reduction equals 20mg.

How many injections does a 10ml vial of Swiss Pharma Parabolan 76.5mg/ml provide at a typical contest-prep dose?

At a twice-weekly injection schedule of 1.0ml per injection, a single 10ml vial provides ten injections — covering five weeks of competition-phase use. At the lower end of the competition range (0.98ml per injection twice weekly), the same vial supports just over five weeks, making it practical for the latter half of a standard eight-to-twelve week prep cycle without mid-phase restocking.

What are the storage requirements for a Swiss Pharma Parabolan 76.5mg/ml 10ml vial after opening?

After the vial septum has been first punctured, store the vial upright at 15–25°C away from direct light and heat sources; refrigeration is not required but is acceptable. The multi-dose vial should be used within six weeks of first opening. Inspect the oil visually before each draw: discard the vial if cloudiness, particulate matter, or discolouration is observed, as these indicate potential sterility compromise. (2) angle_used

Competition Proven

Swiss Pharma

Parabolan 76.5mg/ml 10ml Vial by Swiss Pharma

Name: Parabolan 76.5mg/ml 10ml Vial by Swiss Pharma
Brand: Swiss Pharma
SKU: INJ-THEX-SWI-76.5-012
Price: 68.00 EUR
Availability: InStock

Swiss Pharma Parabolan 76.5mg/ml is a sterile injectable Trenbolone Hexahydrobenzylcarbonate solution concentrated at 76.5mg per millilitre and packaged in a 10ml multi-dose vial, engineered to deliver the granular volumetric control that competition athletes require when managing androgenic load across the final weeks of contest preparation. The hexahydrobenzylcarbonate ester maintains a sustained intramuscular depot that supports twice-weekly injection intervals, preserving a stable androgenic environment as caloric restriction deepens and lean tissue protection becomes the overriding training priority. Every production batch clears a dual analytical release gate — HPLC potency confirmation at 76.5mg/ml and LAL endotoxin screening — with lot-specific results retrievable via the vial's serialised authentication code before the first draw.

€68.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers precise volumetric dosing increments suited to week-by-week contest-prep adjustments at 76.5mg/ml
Supports lean tissue preservation under a progressive caloric deficit during competition preparation
Provides a ten-injection supply per vial, covering the critical final phase of a standard prep cycle
HPLC-confirmed potency at 76.5mg/ml eliminates the uncertainty of under- or over-dosed vials during peak-week protocols
Hexahydrobenzylcarbonate ester sustains meaningful androgenic plasma levels between twice-weekly injections without daily administration
LAL endotoxin clearance on every batch reduces the risk of injection-site inflammatory response during high-frequency competition prep
Serialised batch documentation enables team physicians to cross-reference vial identity with analytical release records

Phase	dosage	Note
Early Contest Prep (Weeks 8–5 out)	153mg/week (1.0ml twice weekly)	Introductory competition-phase dose; allows tolerance confirmation before final-phase escalation if required
Mid Contest Prep (Weeks 4–2 out)	153–229.5mg/week (1.0–1.5ml twice weekly)	Core competition phase; androgenic support maintained as caloric deficit deepens; monitor cardiovascular markers
Peak Week (Final 7 days before contest)	76.5–153mg/week (0.5–1.0ml twice weekly)	Deliberate load reduction to manage water retention and vascular stress; 0.2ml step-down = 15.3mg per injection

Key takeaways

Target 150–230mg weekly during contest prep for controlled androgenic support.
Use the 76.5mg/ml concentration to calculate peak-week dose reductions precisely.
Introduce Parabolan eight to twelve weeks before competition for stable plasma levels.
Verify batch HPLC documentation via the serialised vial code before each prep phase.
Draw with a 23–25 gauge needle to maintain vial sterility across multiple uses.

Trenbolone Hexahydrobenzylcarbonate in Pre-Contest Bodybuilding: A Dosing-Centred Overview

Swiss Pharma Parabolan 76.5mg/ml is a precision contest-prep injectable in which Trenbolone Hexahydrobenzylcarbonate serves as the sole active agent, formulated at a concentration specifically suited to the incremental dosing adjustments demanded during the final weeks of competitive preparation. Contest preparation fundamentally differs from off-season anabolic phases in that the objective shifts from mass accumulation to the preservation of lean tissue under a progressively deepening caloric deficit — a context where androgenic support must be both potent and controllable. Swiss Pharma's 76.5mg/ml concentration gives coaches and athletes the granular volumetric control needed to step weekly androgen load up or down by small, measurable increments as the competition date approaches.

Contest-Phase Dosing Strategy

Competition-oriented Trenbolone Hexahydrobenzylcarbonate protocols typically introduce the compound eight to twelve weeks out from the contest date, allowing sufficient time for plasma levels to stabilise before the critical final four weeks. Compared to off-season bulking protocols — where weekly Trenbolone doses may be pushed considerably higher — competition-phase practice increasingly favours conservative weekly targets that prioritise tissue retention and androgenic tone over maximum anabolic stimulus. A commonly referenced evidence-informed competition-phase range sits between 150mg and 230mg per week, delivered across two injections; at 76.5mg/ml, this translates to volumes of 0.98ml–1.50ml per injection, fully compatible with standard 3ml syringes and 23–25 gauge needles. The 10ml vial volume covers an eight-to-ten week competition phase at twice-weekly dosing without requiring mid-prep vial replacement, removing one potential source of protocol disruption during the most psychologically demanding training period.

Peak-Week Adjustments

In peak week — the final seven days before competition — many athletes and their coaching teams make deliberate androgenic load reductions to manage water retention and cardiovascular stress. The 76.5mg/ml concentration allows a straightforward volume reduction: decreasing each injection by 0.2ml reduces the per-injection dose by 15.3mg, a clinically meaningful step-down that cruder concentrations do not permit with equal precision.

Quality Infrastructure Supporting Competition Use

Swiss Pharma backs every Parabolan 76.5mg/ml vial with HPLC potency verification and LAL endotoxin clearance at the batch level. Consistency in potency across vials matters acutely during contest prep: a formulation delivering less active hormone than labelled can blunt the androgenic support athletes depend on during the final caloric restriction weeks, while a hot batch creates unpredictable androgenic exposure at a moment when the body is already under significant physiological stress. Swiss Pharma's batch-release documentation is accessible via the serialised vial code, providing athletes and team physicians with verifiable confidence rather than label-only assurance.

Usage

Confirm the batch lot number on the Swiss Pharma Parabolan 76.5mg/ml vial matches the HPLC and LAL documentation before beginning your contest-prep cycle.
Calculate your weekly target dose in milligrams first, then convert to millilitres: divide weekly mg by 76.5 to determine total weekly volume, then split equally across two injections.
Draw using an 18–21 gauge needle for filling the syringe, then swap to a 23–25 gauge, 1–1.5 inch needle for intramuscular injection to minimise injection-site trauma during a high-frequency prep schedule.
Rotate injection sites across the gluteal, lateral deltoid, and vastus lateralis muscles on a structured schedule to prevent localised tissue irritation across the multi-week competition phase.
Administer each injection slowly over 30–45 seconds; aspirate briefly before injection when using gluteal sites to confirm the needle tip is not seated in a vascular structure.
Log each injection date, site, and volume in a prep diary; cross-reference weekly androgenic load against body composition check-in data and cardiovascular readings to inform any peak-week dose reduction decisions.

Warnings

Contraindications: Trenbolone Hexahydrobenzylcarbonate is contraindicated in individuals with existing prostate pathology, hepatic impairment, or known hypersensitivity to androgens. Women of childbearing potential should not use this compound due to virilisation risk. Athletes competing in tested federations must verify their organisation's prohibited substance list before use.

Side Effects: Androgenic side effects including increased sebaceous activity, accelerated scalp hair thinning in genetically susceptible individuals, and mood changes are possible. Trenbolone is associated with night sweats, reduced cardiovascular endurance, and elevated haematocrit — effects that require active monitoring during the intensified training of contest prep. Endogenous testosterone suppression is pronounced and should be anticipated.

Monitoring: Haematocrit, haemoglobin, blood pressure, fasted lipid panels (LDL/HDL ratio), and liver enzyme levels (ALT/AST) should be assessed at the start and midpoint of the competition-prep cycle. Cardiovascular strain is amplified during caloric restriction; resting heart rate and subjective exercise tolerance are practical daily indicators of emerging stress.

PCT: Post-cycle therapy should not be initiated until residual Trenbolone Hexahydrobenzylcarbonate plasma activity has substantially cleared — typically fourteen to eighteen days after the final injection given the ester's extended release depot. A structured PCT protocol using a selective oestrogen receptor modulator (SERM) is recommended; consult a licensed physician for personalised protocol design.

Frequently asked questions

How should Trenbolone Hexahydrobenzylcarbonate dosing be structured during the competition prep phase?: Competition-phase dosing is typically lower and more precisely controlled than off-season use, with weekly targets commonly ranging from 150mg to 230mg split across two injections. At 76.5mg/ml, each injection volume falls between 0.98ml and 1.50ml, allowing fine volumetric adjustments as the contest date approaches. The goal is androgenic tissue support under a caloric deficit, not maximum anabolic stimulus.
How many weeks before a competition should Parabolan 76.5mg/ml be introduced into a prep cycle?: Most competition-focused protocols introduce Trenbolone Hexahydrobenzylcarbonate eight to twelve weeks out from the contest date. This window allows plasma concentrations to stabilise before the critical final four weeks, where the compound's role in lean tissue preservation and hardening becomes most important. Earlier introduction provides more time to assess individual tolerance and adjust the weekly dose.
Is dose reduction recommended in peak week before a competition, and how is it calculated with 76.5mg/ml?: Many athletes and coaching teams deliberately reduce androgenic load in peak week to manage water retention and cardiovascular stress. With Swiss Pharma's 76.5mg/ml concentration, reducing each injection by 0.2ml lowers the per-injection dose by precisely 15.3mg — a meaningful step-down that offers finer control than 100mg/ml formulations, where the same 0.2ml reduction equals 20mg.
How many injections does a 10ml vial of Swiss Pharma Parabolan 76.5mg/ml provide at a typical contest-prep dose?: At a twice-weekly injection schedule of 1.0ml per injection, a single 10ml vial provides ten injections — covering five weeks of competition-phase use. At the lower end of the competition range (0.98ml per injection twice weekly), the same vial supports just over five weeks, making it practical for the latter half of a standard eight-to-twelve week prep cycle without mid-phase restocking.
What are the storage requirements for a Swiss Pharma Parabolan 76.5mg/ml 10ml vial after opening?: After the vial septum has been first punctured, store the vial upright at 15–25°C away from direct light and heat sources; refrigeration is not required but is acceptable. The multi-dose vial should be used within six weeks of first opening. Inspect the oil visually before each draw: discard the vial if cloudiness, particulate matter, or discolouration is observed, as these indicate potential sterility compromise. (2) angle_used

Manufacturer

Swiss Pharma's approach to product authenticity for its Parabolan 76.5mg/ml is built on a physical-plus-digital verification architecture that begins at the vial label and extends to retrievable batch-level analytical records. Each 10ml vial carries a holographic security seal and a serialised alphanumeric code; when queried through Swiss Pharma's verification channel, this code returns the specific batch's HPLC potency chromatogram and LAL endotoxin test certificate — not a generic brand-level quality statement, but data tied to the precise production run that filled that vial. For competition athletes and their coaching staff, this traceability matters: the ability to confirm that the compound in hand matches the analytical specification reduces one variable in an already complex prep equation. Counterfeit resistance is built into the hologram specification, which incorporates optically variable elements not reproducible by standard printing methods, enabling rapid visual authentication at point of receipt.

Product details

Brand	Swiss Pharma
Active ingredient	trenbolone hexahydrobenzylcarbonate
Also known as	Parabolan, Tren Hex, Trenbolone Hexa, Swiss Pharma Parabolan
Strength	76.5 mg
Form	Vial
Pack size	1 piece
Item number	INJ-THEX-SWI-76.5-012

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Parabolan 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Parabolan 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Parabolan by Balkan Pharmaceuticals is a pharmaceutical-grade injectable containing Trenbolone Hexahydrobenzylcarbonate at 100 mg/ml — a compound whose clinical origins trace back to the French pharmaceutical industry of the 1960s, making it one of the few anabolic steroids with a documented human-medicine approval history. Each 1 ml glass ampoule delivers a single, pre-measured dose of this long-acting trenbolone ester, preserving compound integrity from fill to injection. Batch release is governed by validated HPLC quantification and LAL endotoxin screening carried out under EU GMP Annex 1 conditions at Balkan Pharmaceuticals' Chișinău facility.

€58.00

Parabol-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Parabol-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Parabol-100 is a single-dose injectable solution of Trenbolone Hexahydrobenzylcarbonate at 100mg/ml, distinguished by its extended pharmacokinetic profile — the hexahydrobenzylcarbonate ester delivers a sustained plasma half-life of approximately 14 days, enabling infrequent injection schedules without compromising hormonal stability. Ten individually sealed 1ml ampoules provide precise, contamination-free dosing across a full cycle. Each production batch undergoes HPLC-verified potency assay and LAL endotoxin testing; GMP certification governs the entire manufacturing chain at BM Pharmaceuticals' facility.

€64.00

High Concentration

Parabolan 100 100mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Parabolan 100 delivers Trenbolone Hexahydrobenzylcarbonate at 100mg per millilitre across a 10ml vial — purpose-built for integration into structured modern cycle protocols where dosing precision and intra-cycle flexibility are non-negotiable. Its slow-release ester kinetics allow straightforward twice-weekly scheduling without the management overhead associated with shorter esters, making it a logical anchor compound in both bulking and recomposition phases. Quality is assured through batch-specific HPLC concentration verification and LAL endotoxin testing applied at the fill-and-finish stage of every production run.

€68.00

Brand Quality

Hexos 75mg/ml 10ml Vial by Driada Medical

Hexos by Driada Medical delivers Trenbolone Hexahydrobenzylcarbonate at 75mg per millilitre in a sterile 10ml multi-dose vial, engineered as the structural centrepiece of a periodised blast-and-cruise framework that demands precise hormonal control at every phase boundary. The 75mg/ml concentration gives practitioners a uniquely granular dosing unit — each 0.5ml increment equals 37.5mg — enabling stepwise escalation into a blast or progressive reduction toward cruise without the rounding compromises inherent to higher-concentration formats. Batch quality is enforced by Driada Medical through HPLC-confirmed potency verification, LAL endotoxin clearance, and full GMP-compliant manufacturing documentation traceable to the specific production lot.

€70.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00